Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5268840 | 1.00 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL407788 | 1.00 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL28585467 | 0.98 | SLC6A2 (0.55) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL28585466 | 0.98 | SLC6A2 (0.55) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL7403762 | 0.93 | PLA2G10 (0.53) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL8935465 | 0.93 | BLM (0.53) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL27320071 | 0.87 | BLM (0.47) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL9515271 | 0.86 | BLM (0.46) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL122295 | 0.86 | BLM (0.72) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL202327 | 0.86 | BLM (0.72) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3535310-B1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | COCA COLA CO (US) | 2025-12-24 | — | — | EP | claimed |
| US-11708454-B2 | Acrolein scavenging in PTF and other 1,3-propanediol derived polymers | THE COCA-COLA COMPANY (US) | 2023-07-25 | — | — | US | claimed |
| US-20190330420-A1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | THE COCA-COLA COMPANY (US) | 2019-10-31 | — | — | US | claimed |
| EP-3535310-A1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | The Coca-Cola Company (US) | 2019-09-11 | — | — | EP | claimed |
| CN-109996830-A | Acrolein scavenger in PTF and other 1, 3-propanediol derived polymers | 可口可乐公司 | 2019-07-09 | — | — | CN | claimed |
| CN-1942179-B | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders | NEWRON PHARM SPA | 2010-08-11 | — | — | CN | claimed |
| CN-101466366-A | Alpha-aminoamide derivatives for the treatment of cognitive disorders | NEWRON PHARM SPA (IT) | 2009-06-24 | — | — | CN | claimed |
| CN-1942179-A | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders | NEWRON PHARM SPA (IT) | 2007-04-04 | — | — | CN | claimed |
| EP-3535310-B1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | COCA COLA CO (US) | 2025-12-24 | — | — | EP | disclosed |
| US-11708454-B2 | Acrolein scavenging in PTF and other 1,3-propanediol derived polymers | THE COCA-COLA COMPANY (US) | 2023-07-25 | — | — | US | disclosed |
| US-11124482-B2 | C-met modulators and methods of use | EXELIXIS, INC. (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210253530-A9 | C-MET MODULATORS AND METHODS OF USE | EXELIXIS, INC. | 2021-08-19 | — | — | US | disclosed |
| US-20200331860-A1 | C-Met Modulators and Methods of Use | EXELIXIS INC (US) | 2020-10-22 | — | — | US | disclosed |
| US-20190330420-A1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | THE COCA-COLA COMPANY (US) | 2019-10-31 | — | — | US | disclosed |
| US-6465684-B2 | DIASTEREOMER COMPLEX OF AT LEAST THREE COMPOUNDS, AT LEAST ONE IS A RESOLVING AGENT IN OPTICALLY ACTIVE FORM, AND AT LEAST ONE IS AN ENANTIOMER IN OPTICALLY ACTIVE FORM; RAPID SEPARATION | DSM N.V. (NL) | 2002-10-15 | — | — | US | disclosed |
| US-20010051747-A1 | Process for the separation of a mixture of enantiomers | DSM N.V. | 2001-12-13 | — | — | US | disclosed |
| US-6235927-B1 | OPTICAL RESOLUTION OF ENANTIOMORPHS OF COMPLEXES | DSM N.V. (NL) | 2001-05-22 | — | — | US | disclosed |
| EP-0838448-A1 | Process for the separation of a mixture of enantiomers | DSM N.V. (NL) | 1998-04-29 | — | — | EP | disclosed |
| EP-0231546-B1 | PROCESS FOR THE PREPARATION OF ALPHA-AMINO-ALPHA-METHYLCARBOXYLIC ACID AMIDES AND ALPHA-AMINO-ALPHA-CYCLOALKYLCARBOXYLIC ACID AMIDES | STAMICARBON B.V. (NL) | 1990-11-07 | — | — | EP | disclosed |
| EP-0231546-A1 | Process for the preparation of alpha-amino-alpha-methylcarboxylic acid amides and alpha-amino-alpha-cycloalkylcarboxylic acid amides | STAMICARBON B.V. (NL) | 1987-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331860-A1 | C-Met Modulators and Methods of Use | FLT4, FLT1, MET | SLC6A2 3028/4885TAAR1 3372/4885SMN1; SMN2 4421/4885 |
| US-20210253530-A9 | C-MET MODULATORS AND METHODS OF USE | FLT4, FLT1, MET | SLC6A2 3028/4885TAAR1 3372/4885SMN1; SMN2 4421/4885 |
| US-20010051747-A1 | Process for the separation of a mixture of enantiomers | EPHX2, VKORC1, ALDH1A2 | SLC6A2 4434/4885TAAR1 4282/4885SMN1; SMN2 3530/4885 |
| US-11124482-B2 | C-met modulators and methods of use | FLT4, FLT1, MET | SLC6A2 3028/4885TAAR1 3372/4885SMN1; SMN2 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.